In patients with luminal-like cancer, those with high LAT1-expressing tumors had a significantly lower BCSS than those with low LAT1-expressing tumors (HR = 2.86; 95% CI 1.26–6.48; p = 0.012; Fig. 2a). This evidence concerns the gene LAT and cancer.